Atlas Trials

SAlt Diet and Various Biomarkers Effects on Blood Pressure and Proteinuria During Inhibition of VEGF)

Clinical trial NCT03842917 · COMPLETED

Trial details

NCT number
NCT03842917
Sponsor
University Hospital, Tours
Status
COMPLETED
Study type
OBSERVATIONAL
Patient Starting BevacizumabCancer
Start date
2019-04-26
Primary completion
2022-04-27
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.